Global Assisted Reproductive Technology Market size was USD 28.5 billion in 2024 and is projected to reach USD 52.3 billion by 2033, with a CAGR of 7.0% during the forecast period.
The global assisted reproductive technology (ART) market is experiencing robust growth, driven by rising infertility rates worldwide, increasing acceptance of advanced fertility treatments, and continuous advancements in genetic testing and cryopreservation for improved success rates. ART technologies, encompassing IVF, ICSI, AI, and PGT, are highly regarded for their ability to address male and female infertility, enable genetic screening, and support family planning through fresh/frozen donor procedures and embryo banking. Between 2021 and 2023, market progression was accelerated by delayed parenthood trends, expanded access to fertility clinics, and refinements in fresh non-donor IVF for higher implantation rates. Notable patterns highlight the supremacy of IVF for its versatility, the lead of fresh non-donor procedures for optimal outcomes, and the escalation of female infertility applications due to lifestyle factors. North America commands the primary portion, directed by the United States with its robust insurance coverage and clinic networks. Asia Pacific stands as the most dynamic area, stimulated by medical tourism and rising incomes in India. Obstacles like elevated treatment expenses, ethical debates over embryo selection, and regulatory variations for surrogacy continue, yet prospects in AI-assisted embryo selection and budding economies propel progression through 2033. Conversations regarding affordability and ethics emphasize the requirement for inclusive frameworks, acknowledging providers harmonizing success with societal norms.
Research Objective
MARKET SEGMENTATION
Scope of the Study
Key Questions Answered in the Report
Chapter 1 Research Methodology
1.1 Research Objective
1.2 Market Research Process
1.2.1 Data Procurement and Data Mining
1.2.2 Data Analysis and Standardization
1.2.3 Data Processing and Market Formulation
1.2.4 Data Validation
1.3 Market Research Approach
1.3.1 Residential Research
1.3.2 Commercial Research
1.3.3 Assumptions & Limitations
1.4 Year Considered for the Study
Chapter 2 Executive Summary
2.1 Global Assisted Reproductive Technology Market Snapshot
2.2 Global Assisted Reproductive Technology Market
Chapter 3 Market Variables and Scope
3.1 Introduction to Assisted Reproductive Technology
3.2 Classification and Scope
Chapter 4 Market Dynamics and Trends
4.1 Global Assisted Reproductive Technology Market Dynamics
4.2 Global Assisted Reproductive Technology Market Dynamics, Impact Analysis
4.3 Market Drivers
4.3.1 Driver 1
4.3.2 Driver 2
4.4 Market Restraints
4.4.1 Restraint 1
4.4.2 Restraint 2
4.5 Market Opportunity
4.5.1 Opportunity 1
4.5.2 Opportunity 2
Chapter 5 Premium Insights
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of Substitute Types
5.1.4 Rivalry among Existing Firms
5.1.5 Threat of New Entrants
5.2 Supply Chain Analysis
5.3 Market Share Analysis of Key Players, 2024
5.4 Market Entry Strategy Assessment
5.5 Strategic Recommendation for Stakeholders
Chapter 6 Global Assisted Reproductive Technology Market, By Technology
6.1 Global Assisted Reproductive Technology Market, By Technology, 2025 - 2033
6.2 In Vitro Fertilization (IVF)
6.3 Intracytoplasmic Sperm Injection (ICSI)
6.4 Artificial Insemination (AI)
6.5 Gamete Intrafallopian Transfer (GIFT)
6.6 Zygote Intrafallopian Transfer (ZIFT)
6.7 Preimplantation Genetic Testing (PGT)
6.8 Others
Chapter 7 Global Assisted Reproductive Technology Market, By Procedure Type
7.1 Global Assisted Reproductive Technology Market, By Procedure Type, 2025 - 2033
7.2 Fresh Donor
7.3 Frozen Donor
7.4 Fresh Non-Donor
7.5 Frozen Non-Donor
7.6 Embryo Banking
Chapter 8 Global Assisted Reproductive Technology Market, By Donor Type
8.1 Global Assisted Reproductive Technology Market, By Donor Type, 2025 - 2033
8.2 Known Donor
8.3 Anonymous Donor
8.4 Egg Donor
8.5 Sperm Donor
8.6 Embryo Donor
Chapter 9 Global Assisted Reproductive Technology Market, By Application
9.1 Global Assisted Reproductive Technology Market, By Application, 2025 - 2033
9.2 Male Infertility
9.3 Female Infertility
9.4 Genetic Disorders
9.5 Others
Chapter 10 Global Assisted Reproductive Technology Market, By End-Use
10.1 Global Assisted Reproductive Technology Market, By End-Use, 2025 - 2033
10.2 Fertility Clinics
10.3 Hospitals
10.4 Surgical Centers
10.5 Research Institutes
10.6 Others
Chapter 11 Global Assisted Reproductive Technology Market, By Region
11.1 Overview
11.2 North America
11.2.1 North America Assisted Reproductive Technology Market, By Country
11.2.2 North America Assisted Reproductive Technology Market, By Technology
11.2.3 North America Assisted Reproductive Technology Market, By Procedure Type
11.2.4 North America Assisted Reproductive Technology Market, By Donor Type
11.2.5 North America Assisted Reproductive Technology Market, By Application
11.2.6 North America Assisted Reproductive Technology Market, By End-Use
11.2.7 United States
11.2.7.1 United States Assisted Reproductive Technology Market, By Technology
11.2.7.2 United States Assisted Reproductive Technology Market, By Procedure Type
11.2.7.3 United States Assisted Reproductive Technology Market, By Donor Type
11.2.7.4 United States Assisted Reproductive Technology Market, By Application
11.2.7.5 United States Assisted Reproductive Technology Market, By End-Use
11.2.8 Canada
11.2.8.1 Canada Assisted Reproductive Technology Market, By Technology
11.2.8.2 Canada Assisted Reproductive Technology Market, By Procedure Type
11.2.8.3 Canada Assisted Reproductive Technology Market, By Donor Type
11.2.8.4 Canada Assisted Reproductive Technology Market, By Application
11.2.8.5 Canada Assisted Reproductive Technology Market, By End-Use
11.2.9 Others
11.2.9.1 Others Assisted Reproductive Technology Market, By Technology
11.2.9.2 Others Assisted Reproductive Technology Market, By Procedure Type
11.2.9.3 Others Assisted Reproductive Technology Market, By Donor Type
11.2.9.4 Others Assisted Reproductive Technology Market, By Application
11.2.9.5 Others Assisted Reproductive Technology Market, By End-Use
11.3 Europe
11.3.1 Europe Assisted Reproductive Technology Market, By Country
11.3.2 Europe Assisted Reproductive Technology Market, By Technology
11.3.3 Europe Assisted Reproductive Technology Market, By Procedure Type
11.3.4 Europe Assisted Reproductive Technology Market, By Donor Type
11.3.5 Europe Assisted Reproductive Technology Market, By Application
11.3.6 Europe Assisted Reproductive Technology Market, By End-Use
11.3.7 United Kingdom
11.3.7.1 United Kingdom Assisted Reproductive Technology Market, By Technology
11.3.7.2 United Kingdom Assisted Reproductive Technology Market, By Procedure Type
11.3.7.3 United Kingdom Assisted Reproductive Technology Market, By Donor Type
11.3.7.4 United Kingdom Assisted Reproductive Technology Market, By Application
11.3.7.5 United Kingdom Assisted Reproductive Technology Market, By End-Use
11.3.8 Germany
11.3.8.1 Germany Assisted Reproductive Technology Market, By Technology
11.3.8.2 Germany Assisted Reproductive Technology Market, By Procedure Type
11.3.8.3 Germany Assisted Reproductive Technology Market, By Donor Type
11.3.8.4 Germany Assisted Reproductive Technology Market, By Application
11.3.8.5 Germany Assisted Reproductive Technology Market, By End-Use
11.3.9 France
11.3.9.1 France Assisted Reproductive Technology Market, By Technology
11.3.9.2 France Assisted Reproductive Technology Market, By Procedure Type
11.3.9.3 France Assisted Reproductive Technology Market, By Donor Type
11.3.9.4 France Assisted Reproductive Technology Market, By Application
11.3.9.5 France Assisted Reproductive Technology Market, By End-Use
11.3.10 Italy
11.3.10.1 Italy Assisted Reproductive Technology Market, By Technology
11.3.10.2 Italy Assisted Reproductive Technology Market, By Procedure Type
11.3.10.3 Italy Assisted Reproductive Technology Market, By Donor Type
11.3.10.4 Italy Assisted Reproductive Technology Market, By Application
11.3.10.5 Italy Assisted Reproductive Technology Market, By End-Use
11.3.11 Spain
11.3.11.1 Spain Assisted Reproductive Technology Market, By Technology
11.3.11.2 Spain Assisted Reproductive Technology Market, By Procedure Type
11.3.11.3 Spain Assisted Reproductive Technology Market, By Donor Type
11.3.11.4 Spain Assisted Reproductive Technology Market, By Application
11.3.11.5 Spain Assisted Reproductive Technology Market, By End-Use
11.3.12 Others
11.3.12.1 Others Assisted Reproductive Technology Market, By Technology
11.3.12.2 Others Assisted Reproductive Technology Market, By Procedure Type
11.3.12.3 Others Assisted Reproductive Technology Market, By Donor Type
11.3.12.4 Others Assisted Reproductive Technology Market, By Application
11.3.12.5 Others Assisted Reproductive Technology Market, By End-Use
11.4 Asia Pacific
11.4.1 Asia Pacific Assisted Reproductive Technology Market, By Country
11.4.2 Asia Pacific Assisted Reproductive Technology Market, By Technology
11.4.3 Asia Pacific Assisted Reproductive Technology Market, By Procedure Type
11.4.4 Asia Pacific Assisted Reproductive Technology Market, By Donor Type
11.4.5 Asia Pacific Assisted Reproductive Technology Market, By Application
11.4.6 Asia Pacific Assisted Reproductive Technology Market, By End-Use
11.4.7 China
11.4.7.1 China Assisted Reproductive Technology Market, By Technology
11.4.7.2 China Assisted Reproductive Technology Market, By Procedure Type
11.4.7.3 China Assisted Reproductive Technology Market, By Donor Type
11.4.7.4 China Assisted Reproductive Technology Market, By Application
11.4.7.5 China Assisted Reproductive Technology Market, By End-Use
11.4.8 Japan
11.4.8.1 Japan Assisted Reproductive Technology Market, By Technology
11.4.8.2 Japan Assisted Reproductive Technology Market, By Procedure Type
11.4.8.3 Japan Assisted Reproductive Technology Market, By Donor Type
11.4.8.4 Japan Assisted Reproductive Technology Market, By Application
11.4.8.5 Japan Assisted Reproductive Technology Market, By End-Use
11.4.9 India
11.4.9.1 India Assisted Reproductive Technology Market, By Technology
11.4.9.2 India Assisted Reproductive Technology Market, By Procedure Type
11.4.9.3 India Assisted Reproductive Technology Market, By Donor Type
11.4.9.4 India Assisted Reproductive Technology Market, By Application
11.4.9.5 India Assisted Reproductive Technology Market, By End-Use
11.4.10 South Korea
11.4.10.1 South Korea Assisted Reproductive Technology Market, By Technology
11.4.10.2 South Korea Assisted Reproductive Technology Market, By Procedure Type
11.4.10.3 South Korea Assisted Reproductive Technology Market, By Donor Type
11.4.10.4 South Korea Assisted Reproductive Technology Market, By Application
11.4.10.5 South Korea Assisted Reproductive Technology Market, By End-Use
11.4.11 Australia
11.4.11.1 Australia Assisted Reproductive Technology Market, By Technology
11.4.11.2 Australia Assisted Reproductive Technology Market, By Procedure Type
11.4.11.3 Australia Assisted Reproductive Technology Market, By Donor Type
11.4.11.4 Australia Assisted Reproductive Technology Market, By Application
11.4.11.5 Australia Assisted Reproductive Technology Market, By End-Use
11.4.12 Others
11.4.12.1 Others Assisted Reproductive Technology Market, By Technology
11.4.12.2 Others Assisted Reproductive Technology Market, By Procedure Type
11.4.12.3 Others Assisted Reproductive Technology Market, By Donor Type
11.4.12.4 Others Assisted Reproductive Technology Market, By Application
11.4.12.5 Others Assisted Reproductive Technology Market, By End-Use
11.5 Latin America
11.5.1 Latin America Assisted Reproductive Technology Market, By Country
11.5.2 Latin America Assisted Reproductive Technology Market, By Technology
11.5.3 Latin America Assisted Reproductive Technology Market, By Procedure Type
11.5.4 Latin America Assisted Reproductive Technology Market, By Donor Type
11.5.5 Latin America Assisted Reproductive Technology Market, By Application
11.5.6 Latin America Assisted Reproductive Technology Market, By End-Use
11.5.7 Brazil
11.5.7.1 Brazil Assisted Reproductive Technology Market, By Technology
11.5.7.2 Brazil Assisted Reproductive Technology Market, By Procedure Type
11.5.7.3 Brazil Assisted Reproductive Technology Market, By Donor Type
11.5.7.4 Brazil Assisted Reproductive Technology Market, By Application
11.5.7.5 Brazil Assisted Reproductive Technology Market, By End-Use
11.5.8 Others
11.5.8.1 Others Assisted Reproductive Technology Market, By Technology
11.5.8.2 Others Assisted Reproductive Technology Market, By Procedure Type
11.5.8.3 Others Assisted Reproductive Technology Market, By Donor Type
11.5.8.4 Others Assisted Reproductive Technology Market, By Application
11.5.8.5 Others Assisted Reproductive Technology Market, By End-Use
11.6 Middle East and Africa (MEA)
11.6.1 Middle East and Africa (MEA) Assisted Reproductive Technology Market, By Country
11.6.2 Middle East and Africa (MEA) Assisted Reproductive Technology Market, By Technology
11.6.3 Middle East and Africa (MEA) Assisted Reproductive Technology Market, By Procedure Type
11.6.4 Middle East and Africa (MEA) Assisted Reproductive Technology Market, By Donor Type
11.6.5 Middle East and Africa (MEA) Assisted Reproductive Technology Market, By Application
11.6.6 Middle East and Africa (MEA) Assisted Reproductive Technology Market, By End-Use
11.6.7 United Arab Emirates
11.6.7.1 United Arab Emirates Assisted Reproductive Technology Market, By Technology
11.6.7.2 United Arab Emirates Assisted Reproductive Technology Market, By Procedure Type
11.6.7.3 United Arab Emirates Assisted Reproductive Technology Market, By Donor Type
11.6.7.4 United Arab Emirates Assisted Reproductive Technology Market, By Application
11.6.7.5 United Arab Emirates Assisted Reproductive Technology Market, By End-Use
11.6.8 Others
11.6.8.1 Others Assisted Reproductive Technology Market, By Technology
11.6.8.2 Others Assisted Reproductive Technology Market, By Procedure Type
11.6.8.3 Others Assisted Reproductive Technology Market, By Donor Type
11.6.8.4 Others Assisted Reproductive Technology Market, By Application
11.6.8.5 Others Assisted Reproductive Technology Market, By End-Use
Chapter 12 Competitive Landscape
12.1 Strategic Move Analysis
12.1.1 Top Player Positioning/Market Share Analysis
12.1.2 Top Winning Strategies, By Year, 2021-2024
12.1.3 Competitive Analysis by Revenue, 2022-2024
12.2 Recent Developments by the Market Participants (2024-25)
Chapter 13 Company Profiles
13.1 Merck KGaA (EMD Serono)
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Performance
13.1.4 Product Portfolio
13.1.5 Strategic Growth
13.2 CooperSurgical Inc.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Performance
13.2.4 Product Portfolio
13.2.5 Strategic Growth
13.3 Vitrolife AB
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Performance
13.3.4 Product Portfolio
13.3.5 Strategic Growth
13.4 Cook Medical LLC
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Performance
13.4.4 Product Portfolio
13.4.5 Strategic Growth
13.5 Irvine Scientific (FUJIFILM Corporation)
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Performance
13.5.4 Product Portfolio
13.5.5 Strategic Growth
13.6 Genea Limited
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Performance
13.6.4 Product Portfolio
13.6.5 Strategic Growth
13.7 Thermo Fisher Scientific Inc.
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Performance
13.7.4 Product Portfolio
13.7.5 Strategic Growth
13.8 Esco Micro Pte. Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Performance
13.8.4 Product Portfolio
13.8.5 Strategic Growth
13.9 The Baker Company Inc.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Performance
13.9.4 Product Portfolio
13.9.5 Strategic Growth
13.10 IVFtech ApS
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Performance
13.10.4 Product Portfolio
13.10.5 Strategic Growth
13.11 Hamilton Thorne Ltd.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Performance
13.11.4 Product Portfolio
13.11.5 Strategic Growth
13.12 Kitazato Corporation
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Performance
13.12.4 Product Portfolio
13.12.5 Strategic Growth
13.13 Rocket Medical plc
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Performance
13.13.4 Product Portfolio
13.13.5 Strategic Growth
13.14 INVO Bioscience
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Performance
13.14.4 Product Portfolio
13.14.5 Strategic Growth
13.15 OvaScience Inc.
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Performance
13.15.4 Product Portfolio
13.15.5 Strategic Growth
1. What is driving growth in the assisted reproductive technology market?
Rising global infertility, delayed parenthood, and increasing use of IVF and PGT are key drivers, supported by advancements that improve implantation and success rates.
2. Which technologies and procedures dominate the market?
IVF remains the leading technology due to its versatility, while fresh non-donor procedures hold the largest share because of higher success rates compared to frozen alternatives.
3. What are the main challenges limiting market expansion?
High treatment costs, ethical concerns surrounding embryo selection and surrogacy, and variable success rates, especially in older patients, continue to constrain adoption.
4. Which applications and end-use sectors contribute most to market demand?
Female infertility applications lead due to lifestyle-related factors, and fertility clinics hold the largest share as they offer specialized procedures and advanced laboratory capabilities.
5. Which regions dominate the assisted reproductive technology market?
North America leads the market due to strong insurance coverage and established clinic networks, while Asia Pacific is the fastest-growing region driven by medical tourism and rising incomes.
You can conveniently pay for your desired report through the following payment options:
Upon completing the payment process, a detailed invoice will be promptly sent to your email address. This email will serve as your official receipt for the purchased report. If you encounter any issues or require additional assistance, feel free to reach out to our team, and we’ll be happy to help.
Our reports are accessible in various formats tailored to your needs:
Absolutely! You have the option to purchase individual sections of the report. Simply reach out to our dedicated sales representative, and they will assist you with your request. Feel free to contact our sales team, and they will guide you through the process of obtaining specific sections tailored to your needs.
n adherence to industry standards, all sales are considered final, and payments made are non-refundable. This policy aligns with the unique nature of our business, where a report constitutes a transfer of our market knowledge and understanding.
However, recognizing the importance of client satisfaction, we provide robust post-sales support, including:
$3,499.00
Precise View Reports delivers accurate market insights and tailored industry reports to empower businesses in making informed strategic decisions.
Copyright @2026, All Rights Reserved.